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Actin cytoskeleton–dependent regulation of 
corticotropin-releasing factor receptor heteromers
ABSTRACT Stress responses are highly nuanced and variable, but how this diversity is 
achieved by modulating receptor function is largely unknown. Corticotropin-releasing factor 
receptors (CRFRs), class B G protein–coupled receptors, are pivotal in mediating stress re-
sponses. Here we show that the two known CRFRs interact to form heteromeric complexes 
in HEK293 cells coexpressing both CRFRs and in vivo in mouse pancreas. Coimmunoprecipita-
tion and mass spectrometry confirmed the presence of both CRF1R and CRF2βR, along with 
actin in these heteromeric complexes. Inhibition of actin filament polymerization prevented 
the transport of CRF2βR to the cell surface but had no effect on CRF1R. Transport of CRF1R 
when coexpressed with CRF2βR became actin dependent. Simultaneous stimulation of cells 
coexpressing CRF1R+CRF2βR with their respective high-affinity agonists, CRF+urocortin2, re-
sulted in approximately twofold increases in peak Ca2+ responses, whereas stimulation with 
urocortin1 that binds both receptors with 10-fold higher affinity did not. The ability of CRFRs 
to form heteromeric complexes in association with regulatory proteins is one mechanism to 
achieve diverse and nuanced function.
of extracellular agonists in a spatiotemporal manner. Many GPCRs 
do not operate in isolation, but may “talk” to other receptors and 
proteins via physical association for an integrated and balanced re-
sponse to different stimuli (Vischer et al., 2011). GPCR heteromer-
ization can often modify functional characteristics of the individual 
monomers, including subcellular localization, agonist binding, and 
downstream signaling (Levoye et al., 2006; Springael et al., 2007; 
Milligan, 2009; Vischer et al., 2011). Though most GPCR monomers 
have the capacity to elicit an intracellular signaling response upon 
agonist binding, many GPCRs exist and function as homomeric or 
heteromeric assemblies. For example, the umami and sweet taste 
receptors (TIR) are heterodimeric assemblies of T1R3 in combina-
tion with T1R1 or T1R2, respectively (Zhao et al., 2003). Also, con-
stitutive homodimerization of class B secretin receptors was found 
to facilitate G-protein coupling, which is critical for secretin binding 
(Harikumar et al., 2006; Gao et al., 2009). GPCRs are also known to 
interact with accessory proteins known as receptor activity–modify-
ing proteins (RAMPs). RAMPs regulate the activities of several GP-
CRs, including the receptors for secretin, calcitonin, glucagon, and 
vasoactive intestinal peptide (Sexton et al., 2006). Interaction of 
RAMPs with GPCRs can modulate receptor actions, including chap-
eroning of the receptor to the cell surface, as is the case for the 
calcitonin receptor-like receptor. RAMP present in a heterodimer 
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INTRODUCTION
At any given time, a cell expresses several different G protein–cou-
pled receptors (GPCRs), which enables it to respond to a plethora 
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CRF2βR expressed in HEK293 cells and found this receptor to be 
present both at the cell surface and intracellular compartments, ir-
respective of whether the cells were transiently or stably transfected 
(Figure 1A). To characterize whether CRF2βR from the cell surface 
internalizes with bound agonist, we first used fluorescently labeled 
agonists: 5-carboxyfluorescein–labeled Ucn1 (5-FAM-Ucn1) and 
Rhodamine Red–labeled CRF (Rhod-CRF). HEK293 cells expressing 
CRF1R were used as positive controls, as Ucn1 is known to bind both 
CRFRs with equal affinity in in vitro assays (Vaughan et al., 1995). 
Untransfected HEK293 cells were used as negative controls. The 
5-FAM-Ucn1 bound strongly to cell surface CRF2βR and CRF1R 
(Figure 1, B and C, top panels) and the agonist-bound receptors 
internalized to endosomes within 30 min of incubation (Figure 1, B 
and C, bottom panels). Cell surface CRF2βR did not bind apprecia-
bly to Rhod-CRF and did not show any appreciable internalization 
after 30 min of incubation, whereas CRF1R bound to Rhod-CRF 
showed robust internalization within 30 min of incubation (Figure 1, 
E and F). Importantly, untransfected HEK293 cells did not bind 
5FAM-Ucn1 or Rhod-CRF, nor did they show any discernible expres-
sion of CRFRs (Figure 1, D–G). These results further confirm in vitro 
observations that Ucn1 binds to both CRF1R and CRF2R and takes it 
a step further to show that ligand-bound receptors are internalized.
CRF2βR harbors a cleavable SP
While the SPs for CRF1R and CRF2αR have been studied before 
(Alken et al., 2005; Rutz et al., 2006; Schulz et al., 2010; Teichmann 
et al., 2012), it is unknown whether CRF2βR harbors a pseudo- or 
cleavable SP. Using the Max Planck Institute proteasome cleav-
age prediction site (www.mpiib-berlin.mpg.de/mpiib-cgi/MAPPP/ 
cleavage.pl), we identified putative cleavage domains within the 
first 33 amino acids (Figure 2A). On the basis of this plot and the 
putative cleavage site for CRF2αR (Perrin et al., 2003), we con-
structed a Flag-tagged delta(Δ)SP version of CRF2βR (Flag-
CRF2βRΔSP) lacking the N-terminal 26 amino acids and N-terminal 
hemagglutinin (HA)–tagged and Flag-tagged full-length CRF2βR 
(HA-CRF2βR and Flag- CRF2βR). Schematic representations of all 
tagged constructs used in this study are shown in Figure 2B. Con-
struction of HA-tagged CRF1R (HA-CRF1R) was described by us 
elsewhere (Hasdemir et al., 2012). In HEK293 cells expressing HA-
CRF2βR or Flag- CRF2βR, we were unable to detect the full-length 
receptor using anti-HA or anti-Flag antibodies, whereas the anti-
CRFR1/2 antibody that recognizes the C-terminus of CRFRs clearly 
detected both the HA- and Flag- tagged CRF2βR both at the cell 
surface and in intracellular compartments (Figure 2C). Only intracel-
lular staining was detected with the anti-HA antibody (Figure 2C, 
arrowheads), whereas the Flag tag was not detected at all, suggest-
ing that the N-terminal tags are cleaved off from the nascent pep-
tide. On the other hand, Flag-CRF2βRΔSP was detected with both 
anti-Flag and anti-CRFR1/2 antibodies at the cell surface (Figure 2D). 
HA-tagged CRF1R was used as a positive control, and its expression 
was detected at the cell surface using both anti-HA and anti-CRFR1/2 
antibodies (Figure 2E). When primary antibody was omitted, no 
staining was seen (Figure 2E, bottom panel). These data suggested 
that the N-terminal SP of CRF2βR is cleavable.
Next we confirmed that HEK293 cells expressing either HA-
CRF2βR or Flag-CRF2βRΔSP showed similar subcellular localization 
of the receptors both under basal unstimulated and agonist-stimu-
lated conditions (Figure 3, A and B). Under unstimulated conditions, 
both the full-length and ΔSP versions of CRF2βR showed both cell 
surface and intracellular localization. Stimulation with Ucn1, a high-
affinity agonist, or Ucn2, a lower-affinity but CRF2R-specific agonist, 
resulted in internalization of CRF2βRs (Figure 3, A and B, middle and 
may modulate other functions, such as receptor internalization and 
recycling and downstream signaling pathways (Sexton et al., 2006).
Stress responses to the same stressor are highly individualized 
and nuanced. An ancient family of neuropeptide hormones known 
as the corticotropin-releasing factor (CRF) family that comprises four 
known agonists, CRF and urocortins (Ucn1–3), mediates stress re-
sponses. The neuropeptide hormone CRF is primarily responsible 
for regulating and/or initiating stress responses via activation of the 
hypothalamic–pituitary–adrenal axis (Muglia et al., 1995), whereas 
urocortins play a vital role in the recovery response to stress 
(Neufeld-Cohen et al., 2010). These neuropeptides mediate their 
effect via two known class B GPCRs, CRF1R and CRF2R. CRF2R has 
three splice variants in humans: CRF2αR, CRF2βR, and CRF2γR. 
CRF1R and CRF2R have different agonist binding affinities as deter-
mined using in vitro binding assays. CRF has a relatively higher affin-
ity for CRF1R compared with CRF2R. Ucn1 has equal affinity for both 
receptors, but a 10-fold higher binding affinity than that displayed 
by CRF, and Ucn2 and Ucn3 are selective for CRF2R (Vaughan et al., 
1995; Lewis et al., 2001; Reyes et al., 2001).
Stressors activate both CRF1R and CRF2R receptors. CRF1R acti-
vation mediates adrenocorticotropic hormone release, anxiety-like 
behavior, and short-term anorexia, whereas CRF2R activation medi-
ates stress-coping responses, including anxiolytic behavior and long-
term anorexia (Hotta et al., 1999; Reyes et al., 2001). Acute stress 
induces a comprehensive and integrated response to maintain 
homeostasis and survival of organisms. The absence of proper coun-
terregulation might lead to exaggerated stress responses and detri-
mental consequences for the organism (Chrousos, 2009). Therefore, 
the counterbalancing actions of CRF2R might be critical under a 
stressful condition. Many organs and cell-types coexpress both CRF 
receptors, which function “hand-in-hand” for an integrated response 
to stress and to bring the system back to homeostatic baseline 
(Bhargava, 2011; Henckens et al., 2016).
CRF1R is known to hetero(di)merize with vasopressin receptor 
V1b to mediate synergistic actions of vasopressin and CRF (Murat 
et al., 2012). As a heteromeric partner of 5HT2A/CRs, CRF1R re-
sponds to serotonin to signal via inositol triphosphate (Magalhaes 
et al., 2010). CRF1R is known to harbor a cleavable signal peptide 
(SP) (Rutz et al., 2006; Schulz et al., 2010) and exists in an equilibrium 
state of monomer/dimer that is already established in the endoplas-
mic reticulum (ER) (Teichmann et al., 2014). CRF2αR, on the other 
hand, harbors a pseudo-SP that is thought to prevent receptor 
oligomerization (Teichmann et al., 2012). Deletion of the SP of 
CRF2αR results in receptors being trapped in the ER (Rutz et al., 
2006). It remains to be established whether CRF2βR harbors a func-
tional or pseudo-SP.
Recently we have shown that a balanced and coordinated ex-
pression of CRF receptors is required for actions of Ucn3 at baseline 
and during inflammation (Mahajan et al., 2014), but it remains to 
be established whether this effect on physiological function in-
volves physical interaction between CRF receptors and formation of 
heteromeric complexes. In this study we determine whether CRF 
receptors form heteromeric complexes and the functional signifi-
cance of this association.
RESULTS
CRF2βR shows both cell surface and intracellular expression
The cellular location of a given GPCR determines its function. Using 
an antibody that recognizes the C-terminus of both CRF1R and 
CRF2R (anti-CRFR1/2), we have previously shown that CRF1R ex-
pressed in HEK293 cells localized mainly to the plasma membrane 
(Hasdemir et al., 2012). We now examined the localization of 
2388 | B. Hasdemir et al. Molecular Biology of the Cell
bottom panels). Quantification of the confo-
cal images demonstrates that, in unstimu-
lated cells, the cell surface expression of 
both CRF2βR constructs was equivalent 
(Figure 3C). Western blot analysis further 
confirmed that both CRF2βR constructs 
were equally expressed (Figure 3D).
Next we ascertained whether deletion of 
SP of CRF2βR alters function. The CRF re-
ceptors signal via coupling to several G pro-
teins to increase intracellular cAMP levels 
(Reisine et al., 1985; Grammatopoulos, 
2012) and/or Ca2+ levels (Hasdemir et al., 
2012). We confirmed that the intracellular 
increase in cAMP and Ca2+ levels mediated 
by unmodified CRF2βR and CRF2βRΔSP 
were similar after Ucn1 or Ucn2 stimulation 
(Figure 3, E and F). This suggests that the 
cleavage of SP of CRF2βR does not affect 
internalization or downstream signaling abil-
ity in the systems examined and that the SP 
is cleaved to obtain a functional receptor.
Identification of CRF receptor 
heteromeric complex and CRFR-
interacting proteins by mass 
spectrometry analysis
Heteromerization of CRF1R with CRF2R has 
not been previously demonstrated. CRF1R is 
shown to exist as a monomer or homo(di)
mer (Teichmann et al., 2014), whereas the 
pseudo-SP of CRF2αR is thought to prevent 
FIGURE 1: CRF2βR shows both cell surface and intracellular localization. (A) HEK293 cells 
transiently or stably expressing CRF2βR were seeded on coverslips and 48 h later fixed and 
immunostained. Using an antibody that recognizes the C-terminus of CRF receptors (anti-
CRFR1/2), we found that CRF2βR localizes to both the cells surface (arrows) and to intracellular 
compartments (arrowheads). (B) HEK293 cells stably expressing CRF2βR were incubated with 
5-carboxyfluorescein–labeled Ucn1 (5-FAM-Ucn1; 100 nM) for 2 and 30 min and immunostained 
with anti-CRFR1/2 antibody (secondary antibody RRX) as in A, and images were captured on a 
Zeiss confocal microscope. At 2 min, Ucn1-bound CRF2βRs were predominantly found at the 
plasma membrane (arrows). At 30 min, Ucn1-bound CRF2βRs co-internalized and showed 
predominantly intracellular localization (arrowheads). (C) Similarly, HEK293 cells stably 
expressing CRF1R were incubated with 100 nM 5-FAM-Ucn1 for 2 and 30 min and 
immunostained with anti-CRF1/2 antibody (secondary antibody RRX) as in B. At 2 min, Ucn1-
bound CRF1Rs were predominantly found at the plasma membrane (arrows). At 30 min, 
Ucn1-bound CRF1Rs co-internalized and showed predominantly intracellular localization 
(arrowheads). (D) HEK293 cells 
(untransfected) were incubated with 
5-FAM-Ucn1 and processed as in B and C. 
The 5-FAM-Ucn1 did not show any 
nonspecific binding. (E) HEK293 cells stably 
expressing CRF2βR were incubated with 
100 nM of Rhodamine Red–labeled CRF 
(Rhod-CRF; 100 nM) for 2 and 30 min and 
processed as in B, except that the secondary 
antibody used was FITC labeled. At 2 and 
30 min, no appreciable binding of Rhod-CRF 
was observed (lack of any red staining), and 
CRF2βR was predominantly found at the 
plasma membrane (green, arrows). 
(F) Similarly, HEK293 cells stably expressing 
CRF1R were incubated with Rhod-CRF and 
processed as in E. At 2 min of incubation, 
little if any Rhod-CRF bound to CRF1R, and 
the receptors were predominantly found at 
the plasma membrane (arrows). After 30 min 
of incubation, Rhod-CRF–bound CRF1R 
co-internalized and showed intracellular 
localization (arrowheads). (G) Untransfected 
HEK293 cells were incubated with Rhod-CRF 
and processed as in E and F. Importantly, 
Rhod-CRF did not show any nonspecific 
binding. Scale bar: 10 μm. Representative 
images are shown (n = 2 coverslips per 
condition, and each experiment was 
performed three times).
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supercomplex, HEK293 cells coexpressing 
epitope-tagged CRFRs (HA-CRF1R+Flag-
CRF2βRΔSP) were stimulated with CRF, and 
the complex was purified. In the absence of 
well-characterized antibodies that distin-
guish between CRF receptors, anti-HA anti-
bodies were used to pull down complexes 
(Figure 4C) and identify interacting partners 
using mass spectrometry (MS), an approach 
used previously by others and by us 
(Bockaert et al., 2004; Gingras et al., 2005; 
Trester-Zedlitz et al., 2005). Immunoprecipi-
tated complexes were separated by SDS–
PAGE (Figure 4C), excised and digested 
with trypsin, and subjected to analysis by 
reverse-phase liquid chromatography–elec-
trospray tandem MS (LC-MS/MS). MS analy-
sis of the proteins that coprecipitated with 
HA-tagged HA-CRF1R in cells coexpressing 
Flag-CRF2βRΔSP revealed hundreds of pro-
teins (Supplemental Table 1). Several of the 
proteins that interacted with CRFR complex 
were specifically enriched compared with 
pull downs of untransfected (mock) cells 
(Figure 4D). As expected, MS analysis de-
tected CRF1R receptor in the multimeric 
receptor–protein complex and confirmed 
the presence of CRF2βR in HEK293 cells co-
expressing both CRFRs and stimulated with 
CRF (Figure 4D and Supplemental Table 1). 
A number of cytoskeleton-associated pro-
teins, including F-actin and filament A, inter-
act with the i3 loop of GPCRs (Binda et al., 
2002; Cornea-Hebert et al., 2002; Kim et al., 
2002). GPCRs undergoing endocytosis 
require cytoskeletal support to mediate 
trafficking. Several proteins critical for traf-
ficking of receptors and maintaining cell 
structure and integrity were coimmunoprecipitated with CRFRs and 
were specifically enriched in receptor complexes according to the 
abundances in immunoprecipitated complex estimated by spectral 
counting. These proteins included tubulin α/β-chain, actin, and heat 
shock protein 70 (Hsp70) proteins (Figure 4D and Supplemental 
Table 1).
To confirm these MS findings and to explore agonist-specific in-
teractions of CRF1R with CRF2βR and the possibility of simultaneous 
receptor activation in presence of multiple agonists, we stimulated 
HEK293 cells coexpressing both receptors with CRF, Ucn2, or Ucn1 
alone, or a cocktail of CRF+Ucn2. Immunoprecipitation (IP) of HA-
CRF1R was performed using anti-HA antibodies and separated by 
SDS–PAGE. As expected, agonist treatment did not affect the 
presence of HA-CRF1R in HEK293 cells coexpressing both CRF re-
ceptors (Figure 4E). Western blot analysis with anti-Flag antibody 
confirmed that Flag-CRF2βRΔSP was coimmunoprecipitated with 
HA-CRF1R (Figure 4F). Additionally, actin was found to interact with 
the CRF receptor complex (Figure 4F, blots 1 and 2, and Supple-
mental Figure S1A) and was not present in the co-IP complex from 
HEK cells alone, although actin was present in inputs from all condi-
tions. We used protease-activated receptor 2 (PAR2), another GPCR 
(Hasdemir et al., 2007) that is unrelated to the CRF family in its func-
tion to validate that actin is a specific interacting partner for CRFRs. 
HEK cells expressing PAR2 with an N-terminal Flag epitope and a 
oligomerization (Teichmann et al., 2012). For ascertaining whether 
CRF receptors are capable of physically interacting and forming 
heteromeric complexes, HEK293 cells were transfected with HA-
CRF1R or Flag-CRF2βRΔSP alone or cotransfected with both HA-
CRF1R+Flag-CRF2βRΔSP. Western blot analysis using anti-CRFR1/2 
antibody that detects both receptors (Chang et al., 2011) revealed 
the presence of CRFR monomers (at ∼75 kDa) and a CRFR multi-
meric complex (at ∼250 kDa) that were not present in untransfected 
HEK293 cells (Figure 4A). In HEK293 cells cotransfected with both 
CRFRs, only a ∼250 kDa band was detected, which suggested that 
CRF1R and CRF2βRΔSP resolve on SDS–PAGE as a multimeric pro-
tein complex, as has been reported for other GPCRs (Vischer et al., 
2015). To ensure that receptor heteromerization was not restricted 
to transfected HEK cells, but is a phenomenon that occurs in vivo, 
without cotransfection in tissues known to express both CRF recep-
tors (pancreas) or only CRF2R (colon), we used protein lysates from 
pancreas and colon tissue to demonstrate presence of a higher 
molecular band in tissue coexpressing both receptors. We observed 
the presence of an ∼250 kDa band, along with CRFR monomers and 
homo- and/or heterodimers in pancreatic tissue lysates from mice, 
whereas only CRFR monomers and dimers were present in colonic 
lysates (Figure 4B).
For further investigation of the CRF1R+CRF2βR interaction 
and identification of other interacting partners in the receptor 
FIGURE 2: CRF2βR harbors a cleavable N-terminal SP. (A) A putative SP of CRF2βR contained 
within the first 33 amino acids (aa) was identified based on the Max Planck Institute proteasome 
cleavage prediction site. The maximum cleavage probability lies within the first 26 amino acids, 
in the domain: LLYVPHLLLCLLCL (blue text). The known SP of CRF1R is contained within the first 
23 aa. (B) Schematic representations of N-terminal epitope-tagged constructs used in this study 
are shown. (C) In HEK293 cells stably expressing HA-CRF2βR, anti-CRFR1/2 antibody detected 
the receptor both at the cell surface (arrows) and in intracellular compartments (arrowheads), 
whereas anti-HA antibody showed only intracellular staining (arrowheads), suggesting that the 
HA tag is cleaved from the nascent receptor. (D) In HEK293 cells stably expressing Flag-
CRF2βRΔSP, both anti-CRFR1/2 and anti-Flag antibodies detected the receptor at the cell surface 
(arrows). (E) In HEK293 cells stably expressing HA-CRF1R, both anti-CRFR1/2 and anti-HA 
antibodies detected the receptor at the cell surface (arrows). In the absence of primary antibody 
(negative control), no staining was visible (bottom). Scale bar: 10 μm. Representative images are 
shown (n = 2 coverslips per condition, and each experiment was performed three times).
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C-terminal HA epitope were used. IP of 
Flag-PAR2-HA was performed using anti-HA 
antibodies and separated by SDS–PAGE. 
While actin was present in all input lanes 
(Figure 4G), actin did not coimmuniprecipi-
tate with Flag-PAR2-HA (Figure 4H and 
Supplemental Figure S1B). Taken together, 
these data suggest that CRF1R interacts 
with CRF2βR both under unstimulated and 
various agonist-stimulated conditions and 
that actin specifically interacts with the CRF 
receptor complex, further confirming our 
MS findings.
CRF1R + CRF2βR heteromerization 
alters agonist-induced internalization 
of CRF1R
We have previously shown that CRF1R traf-
fics and internalizes to early endosomes in 
response to its cognate agonists CRF and 
Ucn1 (Hasdemir et al., 2012). We deter-
mined whether coexpression of CRF2βRΔSP 
with CRF1R alters this trafficking behavior. To 
study trafficking of receptors exclusively 
from the cell surface, we labeled the cell-
surface receptors by incubating the cells 
with anti-HA antibody (for HA-CRF1R) or 
anti-Flag antibody (for Flag-CRF2βRΔSP). We 
have previously demonstrated that surface-
tagged CRF1R trafficked similarly to un-
tagged receptors (Hasdemir et al., 2012), 
as has been observed with other GPCRs 
(Hasdemir et al., 2007). Under unstimulated 
conditions, CRF2βRΔSP and CRF1R ex-
pressed individually were found at the cell 
surface (Figure 5, A–C, row 1, and Figure 5, 
D–G). As expected, CRF stimulation showed 
modest internalization of CRF2βRΔSP (Figure 
5A, row 2, and D), whereas Ucn2 caused 
FIGURE 3: Full-length and ΔSP versions of CRF2βR exhibit similar subcellular localization and 
downstream cAMP and Ca2+ responses. HEK293 cells stably expressing HA-CRF2βR or 
Flag-CRF2βRΔSP were seeded on coverslips and immunostained using anti CRFR1/2 antibody. 
Stimulation with 100 nM of agonists Ucn1 or Ucn2 resulted in internalization (arrowheads) of 
both full-length (A) and ΔSP (B) versions of CRF2βRs from the cell surface (arrows). 
Representative images are shown (n = 2 coverslips per condition, and each experiment was 
performed three times). Scale bar: 10 μm. (C) Quantification of images in row 1 of A and B. The 
percentage of total fluorescence at the cell surface for both versions of CRF2βRs was quantified. 
Cell surface expression was found to be similar between CRF2βR and CRF2βRΔSP (n = 24 cells 
for each condition; two-tailed unpaired Student’s t test: n.s.). (D) Western blot analysis of 
HEK293 cells expressing HA-CRF2βR or Flag-CRF2βRΔSP showed similar receptor expression 
levels with both constructs. Untransfected 
cells were used as negative control. (E) cAMP 
levels increased significantly from baseline 
values upon stimulation with either Ucn1 or 
Ucn2 in a dose-dependent manner (p < 0.05 
vs. baseline values with ligand concentrations 
>1.6 nM; two-tailed unpaired Student’s t test, 
mean ± SEM of three experiments in 
triplicate) in both full-length and ΔSP versions 
of CRF2βRs. Importantly, both versions of 
CRF2βRs showed similar increases in cAMP 
levels at all doses tested (two-tailed unpaired 
Student’s t test: n.s.). (F) Peak [Ca2+]i 
increased in response to 100 nM Ucn1 or 
Ucn2 stimulations in both full-length and ΔSP 
versions of CRF2βRs to a similar degree 
(normalized to peak ionomycin responses). 
Data are mean ± SEM. No significant 
differences were found between CRF2βR and 
CRF2βRΔSP (two-tailed unpaired Student’s t 
test: n.s.). Representative traces of [Ca2+]i are 
shown (n = 3 wells per condition, and each 
experiment was performed three times).
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more robust internalization (Figure 5A, row 2 
vs. row 4, and D; p < 0.0001 vs. unstimulated 
and CRF). As expected, stimulation of cells 
expressing CRF1R with CRF resulted in ro-
bust receptor internalization, whereas Ucn2 
did not (Figure 5B, row 2 vs. row 4, and E; 
p < 0.0001 vs. unstimulated and Ucn2). Ucn1 
that exhibits 10-fold higher binding affinity 
for CRF2R and CRF1R in vitro than CRF or 
Ucn2 (Pal et al., 2010) showed less internal-
ization of CRF2βRΔSP than Ucn2 (Figure 5A, 
row 3, and D; p < 0.01 Ucn2 vs. Ucn1). Ucn1 
stimulation also resulted in internalization of 
CRF1R to a similar degree as CRF (Figure 5B, 
FIGURE 4: CRF1R and CRF2R form heteromeric complexes. (A) Western blot analysis of HEK293 
showed bands at ∼70 kDa and ∼250 kDa in cells transfected with either HA-CRF1R or Flag-
CRF2βRΔSP, whereas only a prominent band at ∼250 kDa was seen in cells cotransfected with 
both HA-CRF1R+Flag-CRF2βRΔSP, suggesting heteromerization and formation of a 
supercomplex. Untransfected cells were used as negative control. (B) Western blot analysis of 
mouse colon or pancreas whole-tissue lysates using anti-CRFR1/2 antibody showed a band at 
∼60 kDa corresponding to the predicted size of CRFR monomers (blue arrow), as well as bands 
at ∼100 kDa and ∼120 kDa, which may represent CRFR dimers (purple arrow). In mouse 
pancreas, an additional strong band at∼250 kDa (orange arrow) was also detected. (C) IPs using 
anti-HA antibody were performed from cotransfected HA-CRF1R+Flag-CRF2βRΔSP HEK293 cell 
lysates stimulated with 100 nM CRF for 30 min. Coomassie blue–stained gel of IPs showed a 
band at ∼250 kDa in lysates from cotransfected, but not untransfected, cells (box). These bands 
were excised and processed for MS. XL, cross-linked; M, marker (n = 3–4 for IP and 
2–3 for MS). (D) MS analysis of the excised 
bands revealed that tubulin α/β-chain, actin, 
and Hsp70 were proteins that were 
specifically enriched in CRF1R+CRF2β 
heteromeric complexes. Scatter plot showing 
relative enrichment of HA-CRF1R associated 
proteins in anti-HA vs. mock pull downs. 
Intervals of confidence for 95% (blue lines) 
and 99.7% (red lines) are indicated. Spectral 
analysis: High-energy collision dissociation–
tandem mass spectra obtained from 
precursor ions with mass 707.7146+3 (CRF1R) 
and 626.9720+3 (CRF2R) found in tryptic 
digests of immunoaffinity pull downs of 
HA-CRF1R corresponding to peptides 
spanning residues S58 to R76 of human 
CRF1R and I93 to R107 of human CRF2R. 
b- and y-type ion series are labeled in the 
figure. (E, F) Co-IPs and Western blots 
showing presence of CRFR heteromeric 
complexes of ∼250 kDa size. Anti-HA or 
anti-Flag antibodies were used in Western 
blot analyses of HA-CRF1R+Flag-CRF2βRΔSP 
cotransfected HEK293 cells to detect 
presence of individual receptor in this 
complex. Cells were stimulated with various 
agonists (100 nM) as indicated, and IP was 
performed using anti-HA antibody. Both the 
cell lysate inputs (E) and IPs (F) show bands at 
∼250 kDa in unstimulated and various 
agonist-stimulated cells. Biological replicates 
of IPs are shown in F, blots 1 and 2, and 
Supplemental Figure S1A. The blots were 
also probed for β-actin, confirming that input 
had similar levels of total protein and showing 
that β-actin is coimmunoprecipitated with the 
CRF receptor complex. Untransfected cells 
were used as negative control, and no major 
bands were detected in IP with either 
anti-HA, anti-Flag, or anti–β-actin antibodies. 
(G, H) Co-IPs and Western blots showing 
presence of Flag-PAR2-HA detected by either 
HA or Flag antibodies in stably expressing 
HEK293 cells. Both the cell lysate inputs 
(G) and IPs (H) show PAR2 as a characteristic 
smear from ∼250 kDa to ∼30 kDa due to 
various posttranslational modifications. While 
actin was unequivocally present in the input; 
actin did not coimmunoprecipitate with 
Flag-PAR2-HA or untransfected HEK293 cells 
that were used as negative control.
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row 3, and E), suggesting that in vitro bind-
ing affinities that take only the ligand-bind-
ing domain of the receptor into account, 
may not reflect how the receptor may be-
have when expressed in its native form. In 
cells coexpressing CRF1R+CRF2βRΔSP, im-
age quantification showed that both CRF 
receptors were expressed at similar levels 
at the cell surface (Figure 5F) with little intra-
cellular colocalization (Figure 5G). Both re-
ceptors internalized upon CRF stimulation 
(Figure 5C, panel 3, row 2, and F; p < 0.0001 
vs. unstimulated) and robust colocalization 
was evident (Figure 5G). Ucn1 had similar ef-
fects and resulted in internalization and colo-
calization of the two coexpressed receptors 
in intracellular vesicles (Figure 5C, panel 3, 
row 3, F, and G; p < 0.0001 vs. unstimu-
lated). Ucn2 stimulation resulted in little 
cointernalization or intracellular colocaliza-
tion (Figure 5C, panel 3, row 4, F, and G). 
Upon Ucn2 stimulation, CRF1R+CRF2βRΔSP 
remained largely localized to the plasma 
membrane, and only what appeared to be 
the CRF1R-dissociated portion of CRF2βRΔSP 
was found to be intracellular (Figure 5F), as 
was evident by little colocalization of intra-
cellular CRF2βRΔSP with CRF1R (Figure 5C, 
panel 3, row 4, and Figure 5G). Simultane-
ous stimulation of the receptor with 
CRF+Ucn2 resulted in robust internalization 
and colocalization in the cytoplasm of both 
receptors (Figure 5C, panel 3, row 5, F, and 
G; p < 0.0001 vs. unstimulated). Importantly, 
total colocalization coefficient of CRF recep-
tors in unstimulated conditions and upon 
stimulation with various ligands was similar 
(Figure 5G). These observations suggest 
that coexpression of CRF1R and CRF2βRΔSP 
FIGURE 5: CRF1R+CRF2βR heteromers show altered trafficking upon agonist stimulation. For 
elucidation of internalization of CRF receptors expressed on the cell surface, HEK293 cells 
transiently transfected with Flag-CRF2βRΔSP or HA-CRF1R or cotransfected with both CRFRs 
were incubated with either anti-Flag, anti-HA, or both antibodies together for 45 min, washed, 
stimulated with buffer (unstimulated control) or different agonists for 30 min, fixed with 4% 
paraformaldehyde, and immunostained. (A) In cells transfected with Flag-CRF2βRΔSP alone, 
CRF2βRΔSP translocated from the plasma membrane to intracellular vesicles upon Ucn1, Ucn2, 
or CRF+Ucn2 stimulations, but not upon CRF stimulation. (B) In cells transfected with HA-CRF1R 
alone, CRF1R translocated from the plasma membrane to intracellular vesicles after CRF, Ucn1, 
or CRF+Ucn2 stimulations, but not after Ucn2 stimulation. (C) In cells cotransfected with both 
HA-CRF1R+Flag-CRF2βRΔSP, Ucn1 resulted in cointernalization of both receptors, as expected. 
CRF also resulted in cointernalization of both receptors (yellow, merge images), whereas Ucn2 
stimulation appeared to inhibit internalization of both CRF receptors. Costimulation with 
CRF+Ucn2 resulted in internalization of both receptors in cells coexpressing both receptors. 
Representative images are shown (n = 2 coverslips per condition, and each experiment was 
performed three times). Scale bar: 10 μm. Quantification of images of cells transfected with 
(D) Flag-CRF2βRΔSP alone, (E) HA-CRF1R 
alone, or (F) cotransfected with both 
HA-CRF1R+Flag-CRF2βRΔSP. The percentage 
of total fluorescence at the cell surface 
(plasma membrane) was determined for 
each receptor under various stimulations or 
unstimulated conditions (n = 5–23 cells 
per condition). (G) Quantification of 
overlap coefficient (colocalization) of 
HA-CRF1R+Flag-CRF2βRΔSP in cotransfected 
cells under various stimulations or 
unstimulated conditions (overlap coefficient: 
0, no overlap; 1, complete overlap; n = 5–12 
cells per condition). Example cell illustrates 
how the regions of interest were drawn for 
image quantification. Cell surface 
colocalization values were determined as 
follows: total overlap expression coefficient 
− intracellular overlap expression coefficient. 
One-way ANOVA followed by post hoc 
Tukey’s multiple comparisons were 
performed for graphs (D–G), and p values are 
given in the text.
Volume 28 September 1, 2017 CRF receptor heteromers | 2393 
receptors’ Ca2+ or cAMP signaling capabili-
ties as opposed to individually expressed 
CRF1R and CRF2βR. Ca2+ responses of cells 
coexpressing CRF1R+CRF2βRΔSP chal-
lenged by CRF+Ucn2 simultaneously were 
significantly higher than those induced 
by CRF, Ucn2, or Ucn1 individually (Figure 6, 
A and B). When cells coexpressing 
CRF1R+CRF2βRΔSP were simultaneously 
stimulated with CRF+Ucn2, the peak Ca2+ 
signal showed an additive effect compared 
with individually expressing receptors 
(Figure 6B). In contrast to Ca2+ levels, cAMP 
levels were similarly increased after stimula-
tion with individual agonists or simultaneous 
stimulation with CRF+Ucn2 (Figure 6, C and 
D). Thus, while CRF1R+CRF2βRΔSP internal-
ize together as heteromers in response to a 
single agonist, activation and downstream 
coupling with G proteins of both receptors 
after stimulation with their cognate agonists 
may be necessary for functional efficacy. We 
reasoned that Ucn1 that binds both CRF1R 
and CRF2βR with equal, but 10-fold higher 
affinities than either CRF or Ucn2 (Pal et al., 
2010) would induce synergistic cooperation 
of CRFR heteromers and secondary mes-
senger signaling. However, contrary to our 
prediction, stimulation of cells expressing 
CRF1R+CRF2βRΔSP with Ucn1 did not result 
in significantly different Ca2+ responses than 
those observed in cells expressing individ-
ual CRFRs (Figure 6B), whereas cAMP levels 
in coexpressing cells were in between those 
expressing CRF1R or CRF2βRΔSP alone 
(Figure 6D). This suggests that activation of 
the receptor heteromers by Ucn1 was insuf-
ficient to induce synergistic cooperation.
Coexpression of CRF2βR switches 
CRF1R trafficking and signaling from 
an actin-independent to an actin-
dependent pathway
Receptor-mediated endocytosis can occur 
using the actin cytos keleton (Lamaze et al., 
1997). Mass spectrometry analysis of 
CRF1R+CRF2βR multimeric complex revealed actin as an interacting 
partner that coimmunoprecipitated with CRF1R (Figure 4, D–F). We 
investigated whether individually expressed CRF receptors and/or 
CRF1R+CRF2βRΔSP heteromers require polymerization of actin to 
translocate from the ER–Golgi complex to the cell surface and vice 
versa. HEK293 cells expressing only CRF1R continued to show cell 
surface receptor expression even after treatment of cells with cyto-
chalasin D, which inhibits actin polymerization and causes aggrega-
tion of actin filaments on endosomes (Figure 7A, phalloidin red 
stains F-actin). Cytochalasin D treatment led to significant accumula-
tion of CRF2βRΔSP in intracellular vesicles that showed strong 
colocalization with phalloidin (Figure 7A, bottom panel), indicating 
that trafficking and subcellular localization of CRF2βRΔSP was 
disrupted by inhibiting actin polymerization. Importantly, when 
CRF1R+CRF2βRΔSP were coexpressed, treatment with cytochalasin 
D resulted in both CRF receptors being trapped in F-actin 
forms heteromeric complexes that affect one another’s trafficking 
behavior and cointernalize upon specific agonist stimulations.
CRF1R+CRF2βR heteromerization alters agonist-mediated 
intracellular calcium [Ca2+]i and cAMP signaling
It is well established that CRF binds both CRF1R and CRF2R, whereas 
Ucn2 binds exclusively to CRF2R (Pal et al., 2010). We tested the no-
tion that binding affinities might not be directly proportional to re-
ceptor function. In HEK293 cells expressing CRF1R alone, stimulation 
with individual agonists or in combination evoked Ca2+ responses to 
a similar degree (Figure 6, A and B), whereas Ucn2 stimulation did not 
result in a measurable cAMP response (Figure 6, C and D). In HEK293 
cells expressing CRF2βRΔSP alone, Ucn2 stimulation evoked Ca2+ re-
sponses and induced cAMP levels that were approximately twofold 
greater than those induced by CRF (Figure 6, A–D). Next we deter-
mined whether CRF receptor heteromerization alters the coexpressed 
FIGURE 6: CRFR heteromerization alters agonist-mediated calcium and cAMP signaling. Bar 
graphs showing peak [Ca2+] signals or increase in cAMP levels in HEK293 cells expressing CRF1R 
and CRF2βRΔSP and coexpressing CRF1R+CRF2βRΔSP in response to various agonist 
stimulations (100 nM). (A) Stimulation of CRF1R with all agonists resulted in similar peak Ca2+ 
responses, whereas Ucn2 stimulation of CRF2βRΔSP expressing cells resulted in approximately 
twofold higher peak Ca2+ responses. In CRF1R+CRF2βRΔSP coexpressing cells, CRF+Ucn2 
stimulation resulted in ∼1.5-fold higher peak Ca2+ signal compared with stimulation with CRF or 
Ucn1 alone. (B) After stimulation with CRF, cells coexpressing both CRFRs showed 
approximately twofold higher peak Ca2+ signal compared with cells expressing CRF2βRΔSP 
alone. Ucn2 stimulation resulted in approximately twofold higher peak Ca2+ signals in cells 
coexpressing both CRFRs and CRF2βRΔSP alone compared with cells expressing CRF1R alone. 
Simultaneous stimulation with CRF+Ucn2 increased peak Ca2+ signal by approximately twofold 
in cells coexpressing both CRFRs compared with cells expressing individual CRFRs, whereas 
Ucn1, which is known to have equipotent and 10-fold higher binding affinities for both CRFRs, 
did not significantly alter peak Ca2+ signal when both CRF receptors were coexpressed. 
(C) Unlike the other agonists, stimulation of CRF1R with Ucn2 did not result in a measurable 
cAMP response. Ucn2 increased cAMP levels in CRF2βRΔSP-expressing cells and the levels were 
approximately twofold greater than those induced by CRF. (D) In contrast to Ca2+ signals, cAMP 
responses to CRF+Ucn2 stimulation were not higher in CRF1R+CRF2βRΔSP coexpressing cells 
compared with cells expressing CRF2βRΔSP alone. Data are mean ± SEM. Significance was 
calculated by one-way ANOVA Tukey’s multiple comparisons tests. *, p < 0.05; **, p < 0.005; 
^, p < 0.0005; n = 3 wells per condition, and each experiment was performed three times.
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stimulated HEK293 cells expressing indi-
vidual CRFRs or co expressing both recep-
tors with CRF+Ucn2 in the presence or 
absence of cytochalasin D (Figure 7C). Ca2+ 
responses in cells expressing CRF1R were 
not affected by cytochalasin D treatment, 
further confirming our observation that traf-
ficking of CRF1R to the cell surface from an 
intracellular locale does not require pres-
ence of intact actin filaments. However, 
Ca2+ responses in cells expressing 
CRF2βRΔSP alone or coexpressing both 
CRF1R+CRF2βRΔSP were significantly af-
fected by cytochalasin D incubation (Figure 
7C). Treatment of cells with cytochalasin D 
increased Ca2+ responses by 40–50%. The 
additive effect of simultaneous stimulation 
with CRF+Ucn2 was maintained in the pres-
ence of cytochalasin D (Figure 7C). This in-
dicated that disruption of actin polymeriza-
tion specifically affected Ca2+ signaling 
mediated by CRF2β when expressed alone 
and also heteromeric complexes that con-
tain CRF2βR. Thus actin dependence of het-
eromeric CRFR signaling possibly requires 
dual and simultaneous receptor stimulation 
with specific agonists.
DISCUSSION
CRF1R and CRF2R receptor signaling path-
ways are being explored as potential drug 
targets for a plethora of disorders, ranging 
from anxiety and depression to obesity 
(Doyon et al., 2004; Henckens et al., 2016). 
In this study, we made several novel obser-
vations. First, we show that CRF2βR harbors 
a cleavable SP in its N-terminal. Second, 
agonist-binding affinities as defined by in 
vitro assays do not translate to functional 
potencies. For example, both CRF and 
Ucn2 are known to have equal binding af-
finities for CRF2R, but here we show that 
Ucn2 stimulation results in approximately 
twofold higher cAMP/Ca2+ signaling than 
CRF. Third, we show that CRF1R and CRF2R 
interact with other regulatory proteins to 
form multimeric complexes. These high-
mobility complexes were also seen in vivo 
in pancreatic tissue. Interaction of CRF1R 
and CRF2R was confirmed by co-IP and MS. 
Fourth, interaction of CRF1R with CRF2R re-
sulted in cointernalization of both recep-
tors after stimulation with CRF, but not Ucn2 and altered down-
stream intracellular Ca2+ signaling. Finally, we show that trafficking 
of CRF2R, but not CRF1R, is actin dependent. Coexpression of 
both CRF1R and CRF2R results in altering trafficking fate of CRF1R 
from actin independent to actin dependent.
CRF1R is shown to have a cleavable SP, whereas CRF2αR harbors 
a pseudo-SP (Teichmann et al., 2012). Deletion of the putative SP of 
CRF2αR prevents the receptor from exiting the ER (Rutz et al., 2006). 
Here we show that not only does CRF2βR harbor a cleavable SP, but 
it is also functional without its N-terminal SP. The pseudo-SP of 
aggregates (Figure 7B), indicating that the fate of CRF1R depends 
on formation of heteromeric complexes with CRF2βRΔSP that alter 
trafficking of CRF1R from an actin-independent to an actin-depen-
dent pathway.
Destabilization of actin cytoskeleton in polarized Caco2 cells 
inhibits receptor-mediated endocytosis at the apical but not the 
basolateral surface (Gottlieb et al., 1993). Polymerization of actin 
filaments controls formation of clathrin-coated vesicles in a con-
text-dependent manner (Boulant et al., 2011). We investigated the 
role of the actin cytoskeleton in mediating Ca2+ signaling. We 
FIGURE 7: Coexpression of CRF2βR switches CRF1R trafficking from actin-independent to 
actin-dependent. (A) Treatment of HEK293 cells with cytochalasin D, an inhibitor of F-actin 
polymerization resulted in aggregation of F-actin filaments (stained with phalloidin-red, top 
panel). CRF1R continued to show cell surface expression (middle panel), whereas CRF2βRΔSP 
colocalized with F-actin aggregates (bottom panel) after cytochalasin D treatment. (B) In 
HA-CRF1R+Flag-CRF2βRΔSP coexpressing cells, cytochalasin D treatment resulted in both 
receptors being trapped in aggregates, suggesting that trafficking of CRFR heteromers is 
F-actin dependent. Scale bar: 10 μm. Representative images are shown (n = 2 coverslips per 
condition, and each experiment was performed three times). (C) Ca2+ signals in response to 
CRF+Ucn2 stimulation. Bar graphs showing increased peak Ca2+ signals in CRF2βRΔSP and 
CRF1R+CRF2βRΔSP coexpressing cells, but not in CRF1R HEK293 cells after pretreatment with 
cytochalasin D, as compared with buffer treatment. Data are mean ± SEM. Significance was 
calculated by the two-tailed unpaired Student’s t test. **, p < 0.005; n = 3 wells per condition, 
and each experiment was performed three times.
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CRF2αR is thought to prevent oligomerization (Teichmann et al., 
2012); in contrast, CRF2βR without its SP is able to form heteromers 
with CRF1R or homomers. CRF1R is shown to exist as a monomer or 
dimer (Teichmann et al., 2014), and our data from pancreas, colon, 
and transfected HEK293 cells shows that CRF2βR can also exist as 
monomer or dimer.
We observed that in vitro binding affinities of agonists Ucn1 and 
Ucn2 with CRF2R do not necessary translate to trafficking and cAMP 
and/or Ca2+ signaling properties. Ucn1 is known to exhibit a 10-fold 
higher binding affinity to both CRF1R and CRF2R than CRF or Ucn2, 
whereas Ucn2 is known to bind only to CRF2R (Vaughan et al., 1995; 
Lewis et al., 2001; Reyes et al., 2001). Here we found that Ucn2 
stimulation evoked Ca2+ and cAMP responses that were similar in 
magnitude to those seen with Ucn1 in cells expressing CRF2βR. All 
three agonists (CRF, Ucn1, and Ucn2) evoked similar Ca2+ responses 
in cells expressing CRF1R alone, whereas Ucn2 did not increase in-
tracellular cAMP levels in cells expressing CRF1R. CRF, Ucn2, and a 
combination of both agonists significantly increased peak Ca2+ re-
sponses in cells coexpressing both receptors compared with cells 
expressing individual CRF receptors. This is in contrast to Ucn1 
stimulation, where no such differences were seen, despite Ucn1 ex-
hibiting higher affinity for CRF2βR. This is in agreement with pub-
lished data that showed Ucn1 stimulation caused CRF1R to traffic 
through a slower recycling Rab11 pathway (Hasdemir et al., 2012). 
Ucn2 increased cAMP levels in cells coexpressing both receptors, 
whereas Ucn1 dampened the effect. Surprisingly, despite Ucn1 ex-
hibiting equal binding affinities for both receptors, levels of cAMP in 
CRF2βR-expressing cells were twofold higher than CRF1R-express-
ing cells. Interestingly, stimulation of coexpressed CRF receptors 
with Ucn3, another CRF2R-specific agonist was shown to decrease 
Ca2+ responses (Mahajan et al., 2014). Taken together, these data 
strongly suggest that in vitro binding affinities determined using 
ligand-binding domains of receptors may not be reflective of in vivo 
affinities or function. Intracellular cAMP and Ca2+ signaling regulates 
many downstream cellular functions, including changes in phos-
phorylation levels of various MAPK, including ERK1/2. Previous co-
expression studies of CRF1R and CRF2βR in HEK293 cells showed 
that CRF1R did not alter Ucn2-induced activation of cAMP, p38, or 
p42/p44 MAPK (Markovic et al., 2008). Furthermore, heteromeriza-
tion of the two CRF receptors might allow CRF2R-specific agonists 
such as Ucn2 and Ucn3 to regulate functions that are driven by the 
CRF1R or allow for nuanced signaling by high-affinity agonists, such 
as Ucn1. However, the exact nature of this interaction and conse-
quences of preventing CRFR heteromerization require further 
investigation.
Previous studies have suggested CRF receptor cross-talk (Maha-
jan et al., 2014); however, the physical heteromeric interaction of 
CRF receptors or association with ancillary proteins has not been 
demonstrated. Drugs that antagonize one specific CRFR may have 
unintended consequences on CRFR function in cells that coexpress 
both CRFRs. Here we show that CRF1R and CRF2βR interact and 
form heteromers in a multimeric complex with ancillary proteins that 
include cytoskeletal proteins. Trafficking and signaling of hetero-
meric CRFRs is distinct from mono- or homomers and so is their 
dependence on the actin cytoskeleton (model proposed in Figure 
8). The concept of GPCR heteromerization was first introduced by 
Rodbell, who showed that GPCRs were not simple monomeric 
structures but formed large complexes with G proteins and adenylyl 
cyclase (Rodbell, 1995). The functional significance of GPCR het-
eromerizations remains an area not well understood but is emerging 
to be of considerable pathophysiological importance. For example, 
heteromerization of GABAbR1 and GABAbR2 within the ER is 
necessary for adequate GABAbR1 expression on the cell surface 
(Margeta-Mitrovic et al., 2000). The serotonin receptor 5-HT2A/CR 
and vasopressin receptor V1B interact with CRF1R to increase anxi-
ety-like behavior in rats (Magalhaes et al., 2010) or modulate CRF 
function (Murat et al., 2012), respectively.
Several cytoskeleton-associated proteins, including F-actin and 
filamin A, interact with the i3 loop of GPCRs (Binda et al., 2002; 
Cornea-Hebert et al., 2002; Kim et al., 2002), and this study identi-
fied actin, F-actin capping protein, and tubulin as protein partners 
that associate with the CRF1R+CRF2βR heteromeric complex. It is 
possible that the interaction with actin is not “static” but rather an 
agonist-regulated dynamic process. Based on in vitro individual re-
ceptor binding studies, it has been rationalized that Ucn2 and Ucn3 
exert their effects via CRF2R alone, whereas CRF and Ucn1 bind and 
activate both CRF1R and CRF2R (Pal et al., 2010). This might have 
important therapeutic implications, because Ucn2 is implicated in 
the pathophysiology of congestive heart failure and type 2 diabetes 
(Lai et al., 2015). Studies have shown that CRF1R is the principal re-
ceptor involved in stress-adaptive responses, whereas CRF2R func-
tions to dampen the activity of CRF1R and ameliorate stress behav-
ior (Hotta et al., 1999; Reyes et al., 2001).
Upon agonist binding, association of CRF receptors with ancil-
lary proteins such as β-arrestins, clathrins, dynamins, and cytoskele-
ton proteins is essential for proper trafficking and localization of 
these receptors in specific microdomains. Destabilization of actin 
cytoskeleton in polarized Caco2 cells inhibits receptor-mediated en-
docytosis at the apical but not the basolateral surface (Gottlieb 
et al., 1993). Polymerization of actin filaments controls formation of 
clathrin-coated vesicles in a context-dependent manner (Boulant 
et al., 2011). Thus our finding that CRFR heteromers associate 
FIGURE 8: Proposed model for CRFR heteromerization interaction 
with ancillary proteins in a supercomplex. Schematic diagram shows a 
simplified view of CRF receptors trafficking from the endomembrane 
system to the plasma membrane and vice versa. CRF1R traffics to and 
from the endomembrane system to the cell surface in an actin-
independent manner, whereas CRF2βR uses an actin-dependent path 
to traffic to and from the cell surface. Heteromerization of 
CRF1R+CRF2R changes the fate of CRF1R from an actin-independent 
to an actin-dependent trafficking pathway. CRFR heteromers interact 
with ancillary proteins, such as Hsp70, tubulin, and actin.
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constructs: HA-CRF2βR and Flag-CRF2βRΔSP in pcDNA-FRT-5.0 
vector. Forward primer for HA-CRF2βR: 5′GCAGTCTAAGCTTGC-
CACCATG TACCCATACGATGTTCCAGATTACGCTATGAGGGGT-
CCCTCAGG3′ (HindIII site: AAGCTT, Kozak sequence: GCCACC, 
start site: ATG, HA-Tag: TACCCATACGATGTTCCAGATTACGCT, 
hCRF2R sequence: ATGAGGGGTCCCTCAGG). Reverse primer: 
5′CGCAGATCTCGAGTCACACAGCGGCCGTCTGCTTGAT-
GCTG3′ (XhoI site: CTCGAG, stop codon: TGA, hCRFR2 sequence: 
CAAGCAGACGGCCGCTGTG). Flag-CRF2βR: Flag-tagged full-
length CRF2βR was cloned in pCMV-Tag 1 vector (Agilent Technolo-
gies) in BglII and XhoI restriction sites in the multiple cloning se-
quence: forward primer: 5′CAAGATCTTAATGAGGGGTCCCTCA-
GGGCC3′; reverse primer: 5′TGCTCGAGCACAGCGGCCGTCT-
GCTTG3′ (Figure 2B). However, while the receptor expression was 
robust from both the HA- and Flag-tagged constructs as determined 
using the C-terminal antibody, the Flag tag was not detected, 
whereas the HA tag was seen in intracellular vesicles (Figure 2C). 
Thus it was concluded that the N-terminal sequence of the receptor 
is cleaved, irrespective of the tag.
We next made a Flag-tagged construct that lacked the putative SP 
sequence (first 26 amino acids) referred to as delta SP (ΔSP) CRF2R. 
Flag-tagged 27-461-CRF2βR (Flag-CRF2βRΔSP) was amplified using 
Forward primer for Flag-CRF2βRΔSP: 5′AAGCTTGCCACCATGGAC-
TACAAGGACGACGACGACAAGCCGCTCCAATACGCAGCCG3′ 
[HindIII site: AAGCTT, Kozak sequence: GCCACC, start site: ATG, 
Flag-Tag: GACTACAAGGACGACGACGACAAG, hCRF2R sequence: 
CCGCTCCAATACGCAGCCG]. Reverse primer: 5′CTCGAG
TCACACAGCGGCCGTCTGCTTG3′ [XhoI restriction site: 
CTCGAG, stop codon: TGA, hCRFR2 sequence: CAAGCAGACG-
GCCGCTGTG]. High-fidelity Taq polymerase was used for PCR 
amplification. Amplified cDNAs were cloned into the HindIII 
and  XhoI within the multiple cloning site of pcDNA-FRT-5.0 
vector and sequenced to confirm no additional mutations or mis-
matches were present before use in transfection and expression 
studies.
Transfections and generation of stable cell lines
Human embryonic kidney 293 (HEK) cells were grown in DMEM 
containing 10% heat-inactivated fetal bovine serum in 95% air and 
5% CO2 at 37°C and used up to passage 6. HEK-FLP cells stably 
expressing HA-CRF2βR or Flag-CRF2βRΔSP were generated as de-
scribed previously for HA-CRF1R (Hasdemir et al., 2012). In specified 
experiments, HEK cells were transiently transfected using Lipo-
fectamine 2000 according to the manufacturer’s guidelines. Cells 
were plated 48 h before experiments and incubated in DMEM, 0.1% 
bovine serum albumin (BSA) for treatments. HEK-FLP cells stably 
expressing PAR2 with an N-terminal Flag epitope and a C-terminal 
HA epitope described previously (Hasdemir et al., 2007) were used 
as controls for the co-IP experiments.
Immunofluorescence, confocal microscopy, and 
image analysis
HEK293 cells were seeded on poly-d-lysine (100 μg/ml)-coated cov-
erslips in six-well plates at ∼3 × 105 per well. At 48 h posttransfec-
tion, cells were processed for immunofluorescence staining either 
by conventional immunofluorescence method or antibody-tagged 
receptor method to examine trafficking of receptors exclusively 
from the plasma membrane. For conventional immunofluorescence 
staining, cells were incubated with agonists (or not) as indicated. All 
agonists were applied at 100 nM and included CRF, Ucn1, Ucn2, or 
fluorescently labeled agonists: 5-carboxyfluorescein-labeled Ucn1 
(5-FAM-Ucn1) and Rhodamine Red–labeled CRF (Rhod-CRF). Cells 
with actin cytoskeleton to mediate trafficking in a agonist-depen-
dent manner is of interest, because stress conditions and drugs that 
compromise polarization of cytoskeleton proteins may also indi-
rectly affect agonist-receptor signaling at the membrane. Our find-
ings of CRF receptor heteromerization and formation of a multi-
meric complex that signals in an agonist-dependent manner identify 
a novel regulatory mechanism of potential relevance for compound 
pharmacology, because antagonists and drugs that target one CRF 
receptor only can alter function and signaling of interacting CRF re-
ceptors, resulting in off-target side effects.
Migrating and invading carcinoma cells use F-actin–based pro-
trusions to promote trafficking of integrin α/β heteromeric receptors 
(Paul et al., 2015). F-actin remodeling in pancreatic islet cells is in-
duced by glucose, similar to that seen with cytochalasin D (Kalwat 
and Thurmond, 2013), and Ucn2 acting via CRF receptors regulates 
glucose levels in pancreas (Gao et al., 2016). Thus trafficking of CRF 
receptors, specifically that of CRF2R, may be of significance in 
pathophysiological conditions such as diabetes and metabolic 
diseases. The physiological relevance of our observations is further 
validated by other studies that showed colocalization between the 
endogenous CRFRs and actin stress fibers in native uterine smooth 
muscle cells (Markovic et al., 2007). The subapical actin cytoskeleton 
is pivotal in regulating fusion and/or fission of zymogen granule 
membranes with the luminal plasma lemma in the acinar cells, and 
its redistribution is a crucial event responsible for inhibition of Ca2+-
mediated secretion (Singh et al., 2001). Inhibition of actin filament 
polymerization resulted in CRF2βR being trapped in F-actin aggre-
gates, whereas CRF1R continued to traffic to the cell surface, sug-
gesting that individually expressed CRF1R traffics to and from the 
ER–Golgi to the cell surface in an actin-independent manner (Figure 
8). When CRF1R+CRF2βR were coexpressed, inhibition of actin po-
lymerization prevented normal trafficking of CRF1R; both receptors 
colocalized with actin aggregates (Figure 8). Our findings suggest 
that CRF2βR traffics via an actin-dependent path and alters the fate 
of CRF1R trafficking, which may help mediate Ca2+ signaling in dis-
crete intracellular regions; however, the precise mechanism remains 
to be elucidated. 
MATERIALS AND METHODS
Materials
Plasmid and reagents were from the following sources: pcDNA-
FRT-5.0 plasmid and Fura-2AM (ThermoFisher Scientific); Lipo-
fectamine 2000 (Invitrogen); CRF and urocortins (American Peptide); 
trypsin (Gold, Mass Spectrometry Grade; Promega); solvents for in-
gel digestion, UPLC, water, acetonitrile, and formic acid (HPLC grade; 
Fisher Scientific); ionomycin (Life technologies); cytochalasin D (Enzo 
Life Sciences); Alexa Fluor 555 phalloidin red (Cell Signaling).
Primary antibodies were from the following sources: rabbit anti-
HA11, rabbit anti-Flag, mouse anti-Flag, mouse anti–β-actin and 
rabbit anti-actin (Sigma); rat anti-HA11 (Roche); goat anti-CRFR1/2 
(Santa Cruz Biotechnology). Secondary antibodies were from the 
following sources: anti-goat, anti-rabbit, anti-rat immunoglobulin G 
(IgG) coupled to fluorescein isothiocyanate or Rhodamine Red-X 
(Jackson ImmunoResearch Laboratories); anti-mouse or anti-rat or 
anti-rabbit IgG coupled to Alexa Fluor 680 (Invitrogen), and coupled 
to IRDye 800 (Rockland Immunochemicals).
cDNA Constructs
HA-CRF1R cDNA plasmid was previously cloned and described by 
us (Hasdemir et al., 2012). A full-length CRF2βR cDNA plasmid pre-
viously cloned and described by us (Grammatopoulos et al., 2000; 
Hasdemir et al., 2012) was used as a template to make CRF2βR 
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Western blot analysis
Cells were lysed in RIPA buffer as described above. Lysates (30 μg 
of protein) or IP samples were boiled with SDS-sample loading 
buffer, resolved with 10% SDS–PAGE, transferred to polyvinyli-
dene difluoride membranes (Immobilon-FL; Millipore, Billerica, 
MA), blocked for 1 h, and incubated with anti–β-actin or anti-actin 
(1:5000), anti-HA (1:1000), anti-Flag (1:1000), or anti-CRFR1/2 
(1:1000) (2 h at room temperature). Membranes were incubated 
with secondary antibodies conjugated to Alexa Fluor 680 or IRDye 
800 (1:20,000, 1 h at room temperature), and blots were analyzed 
with the Odyssey Infrared Imaging System (Li-Cor Biosciences, 
Lincoln, NE).
Mass spectrometry: reverse-phase LC–MS/MS and 
data analysis
HA-CRF1R and Flag-CRF2βRΔSP were cotransfected in HEK293 
cells, and co-IP was performed as described above. Proteins bound 
to beads were eluted using 0.2 M glycine (pH 2.0) and neutralized 
with 1 M Tris-HCl (pH 8.0), and resolved on a 10% SDS–PAGE. In-gel 
digestion of proteins with trypsin was performed as described previ-
ously (Rosenfeld et al., 1992). Peptides were analyzed in an Orbitrap 
XL (Thermo), in positive ion mode and in information-dependent 
acquisition mode to automatically switch between MS and MS/MS 
acquisition. For each MS spectrum, the six most intense multiply 
charged ions (charge 2–5) over a threshold of 1000 counts were se-
lected for generation of collision-induced dissociation mass spectra. 
A dynamic exclusion window was applied that prevented the same 
m/z from being selected for 1 min after its acquisition. Peak lists were 
generated using PAVA software (Guan et al., 2011). The peak lists 
were searched against the human subset of the SwissProt database 
using Protein Prospector version 5.2.2. A randomized version of all 
entries was concatenated to the database to estimate false discov-
ery rates in the searches. Peptide tolerance in searches was 20 ppm 
for precursor ions and 0.8 Da for product ions, respectively. Peptides 
containing two miscleavages were allowed and included. Carbami-
domethylation of cysteine was allowed as constant modification; 
acetylation of the N terminus of the protein, pyroglutamate forma-
tion from N terminal glutamine, and oxidation of methionine were 
allowed as variable modifications. The number of modifications was 
limited to two per peptide. Protein Prospector thresholds used for 
identification criteria were: minimal protein score of 15, minimal 
peptide score of 15, maximum expectation value of 0.1, and minimal 
discriminant score threshold of 0.0. The false discovery rate was lim-
ited to 1%. Protein hits were considered significant when two or 
more peptide sequences matched a protein entry. Further details 
about identification of fragments and criteria used have been de-
scribed by us elsewhere (Clauser et al., 1999).
Measurement of intracellular calcium [Ca2+]i
Transfected HEK293 cells were grown on 96-well plates (25,000 cells 
were seeded per well; 3–4 wells per condition were used). AT 48 h 
posttransfection, cells were loaded with Fura-2AM, and [Ca2+]i was 
measured as described previously (Hasdemir et al., 2012). Agonist-
induced peak Ca2+ responses were normalized to peak ionomycin-
induced responses. Cells were stimulated with 1 μM ionomycin 90 s 
after agonist (100 nM) stimulation, as indicated in the example Ca2+ 
traces in Figure 3F.
cAMP measurements
Two methods were used for cAMP measurements. The cAMP 
data shown in Figure 3E were derived as follows: full-length, un-
tagged CRF2βR or FLAG-CRF2βRΔSP constructs were transfected 
were washed with phosphate-buffered saline (PBS), fixed with 4% 
paraformaldehyde (20 min, 4°C), washed, and incubated with 
blocking buffer containing 0.1% saponin and 1% heat-inactivated 
normal goat or horse serum for 60 min. Receptors were localized 
using the primary antibodies (anti-HA, anti-Flag, or anti-CRFR1/2; 
1:500, 2 h room temperature) and washed and incubated with sec-
ondary antibodies conjugated to fluorescein isothiocyanate (FITC) 
or Rhodamine Red-X (RRX) (1:200, 1 h room temperature) as previ-
ously described by us (Hasdemir et al., 2012). For staining of actin 
filaments, cells were incubated with Alexa Fluor 555 phalloidin red 
(1:20, 30 min room temperature) after the secondary antibody incu-
bation and then washed before mounting. For studying trafficking 
of receptors expressed on the cell surface, an antibody-tagged 
receptor staining protocol was used. Briefly, cells expressing either 
HA-CRF1R or Flag-CRF2βRΔSP or coexpressing both receptors 
were incubated with rat anti-HA and/or rabbit anti-Flag (1:100, 45 
min at 37°C). Cells were washed and stimulated with 100 nM of 
CRF, Ucn2, Ucn1, or CRF+Ucn2 for 2 and 30 min or with buffer (un-
stimulated controls). Cells were fixed, washed, incubated in block-
ing buffer for 1 h; this was followed by incubation with secondary 
antibodies conjugated to FITC or RRX (1:200, 1 h room tempera-
ture). Cells were imaged with a Zeiss confocal microscope (LSM 
Meta 510; Carl Zeiss, Thornwood, NY) using a Fluor Plan-Apochro-
mat 63× oil-immersion objective (NA 1.4). Images were collected 
and simultaneously processed (colored and merged) using the 
Zeiss (LSM 510) software.
Confocal images were analyzed using Zeiss LSM 510 software. 
Cell surface expression was quantified by drawing regions of inter-
est on the outside and the inside of the plasma membrane (as illus-
trated in Figure 5G), which allowed determination of the percentage 
of total cellular fluorescence at the plasma membrane, as previously 
described (O’Callaghan et al., 2003; Hasdemir et al., 2007). Colocal-
ization of RRX-stained HA-CRF1R (red) and FITC-stained Flag-
CRF2βRΔSP (green) was quantified by measuring the overlap coef-
ficient, with a coefficient of 0 indicating no colocalization and of 1 
indicating complete colocalization within the regions of interest as 
illustrated in Figure 5G.
Receptor Co-IP
HA-CRF1R and Flag-CRF2βRΔSP were cotransfected in HEK293 cells 
in 10 cm dishes (at ∼1 × 106 cells per dish) using Lipofectamine 2000 
(Invitrogen). Untransfected HEK-FLP cells and HEK-FLP cells stably 
expressing Flag-PAR2-HA were used as additional controls. At 48 h 
posttransfection, cells were either vehicle treated or stimulated for 
30 min with 100 nM of CRF, Ucn2, Ucn1, or CRF+Ucn2 together. IP 
was performed from both formaldehyde cross-linked cells or non–
cross-linked cells with both anti-HA and anti-Flag antibodies. Subse-
quently, the cells were washed twice with ice-cold PBS and lysed in 
500 μl RIPA buffer (50 mM Tris/HCl, pH 7.4, 150 mM NaCl, 5 mM 
MgCl2, 1 mM EGTA, 10 mM NaF, 10 mM Na4P2O7, 0.1 mM Na3VO4, 
0.5% Nonidet P-40; supplemented with protease inhibitor cocktail 
[Roche] and phosphatase inhibitor cocktails). Twenty microliters per 
lysate was used as “IP input,” and the rest of the lysate was used for 
IP. Briefly, each lysate was incubated with 2.5 μg rat anti–HA-anti-
body in 500 μl RIPA buffer on a rotor overnight at 4°C. Then 30 μl of 
washed protein A beads (Santa Cruz) was added and incubated on a 
rotor for 1–2 h at 4°C. The slurry was centrifuged at 3000 rpm for 5 
min, and the supernatant was discarded. The beads were washed 
three times with 1 ml RIPA buffer. Then 30 μl of SDS-sample dye was 
added, samples were boiled, and IPs were resolved on a 10% SDS–
PAGE followed by Western blotting with anti-HA, anti-Flag, and 
anti–β-actin or anti-actin antibodies.
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individually in HEK293 cells grown on poly-d-lysine–coated six-well 
plates. Cellular cAMP levels were measured by using Perkin Elmer 
Lance TR-FRET based cAMP assay kits and 96-well white optiplates 
(Perkin Elmer, Cambridge, UK). Briefly, 48 h following transfection, 
cells were removed with 0.25% (wt/vol) trypsin containing 0.53 mM 
EDTA solution, washed with PBS, and resuspended in assay stimula-
tion buffer (PBS with 0.1% BSA and 0.5 mM IBMX). The cells were 
counted with a hemocytometer, and the appropriate cell number 
was pelleted at 500 × g for 4 min and resuspended in stimulation 
buffer with 1/100 Alexa Fluor 647 anti-cAMP antibody at an assay 
concentration of 2000 cells/10 μl. Cells were loaded onto a 96-well 
white optiplate and were stimulated in triplicate with 30 and 100 nM 
of Ucn1 or Ucn2. The plate was incubated in the absence of light for 
30 min before 20 μl/well of detection mix was added. The plate was 
incubated in the dark for a further 60 min. FRET was recorded by 
excitation at 320 nm and emission at 665 nm, using an EnVision 
Xcite multilabel plate reader (Perkin Elmer, Cambridge, UK).
The cAMP data shown in Figure 6, C and D, were derived as 
follows: individually transfected (CRF1R or CRF2βRΔSP) and cotrans-
fected (CRF1R+CRF2βRΔSP) HEK293 cells were grown on poly-d-
lysine–coated 12-well plates and challenged with agonist (100 nM 
CRF, Ucn1, Ucn2, or CRF+Ucn2) or vehicle (giving basal levels). Cells 
were then washed with ice-cold PBS and solubilized with 0.1 M 
HCl/0.1% Triton X-100. The lysates were used to measure levels of 
cAMP with a competitive immunoassay kit (Direct cAMP ELISA Kit; 
Enzo Life Sciences, Farmingdale, NY) according to the manufacturer’s 
guidelines. All cAMP concentrations were corrected for protein levels 
(5 μg of protein per well were used in the enzyme-linked immunosor-
bent assay). Results are expressed as fold increase over basal.
Statistical analysis
Data are presented as mean ± SEM from n ≥ 3 experiments. Prism 
(GraphPad Software, San Diego, CA) was used for statistical analy-
sis. When comparing multiple groups, one-way analysis of variance 
(ANOVA) followed by post hoc Tukey’s multiple comparisons was 
used. When two groups were compared, Student’s t test was used. 
p < 0.05 was considered significant.
ACKNOWLEDGMENTS
We thank Mai Nguyen for her help in making the HA-tagged CRF2βR 
construct. M.W. is a Warwick Medical School Doctoral Training Cen-
tre in Interdisciplinary Biomedical Research student. This work was 
supported by National Institutes of Health grants GM8P41GM103481 
to A. Burlingame and DK080787 to A. Bhargava. B.H. was in part 
supported by T32 AT003997 from the National Institutes of Health/
National Center for Complementary and Integrative Health.
Chang J, Adams MR, Clifton MS, Liao M, Brooks JH, Hasdemir B, Bhargava 
A (2011). Urocortin 1 modulates immunosignaling in a rat model 
of colitis via corticotropin-releasing factor receptor 2. Am J Physiol 
Gastrointest Liver Physiol 300, G884–G894.
Chrousos GP (2009). Stress and disorders of the stress system. Nat Rev 
Endocrinol 5, 374–381.
Clauser KR, Baker P, Burlingame AL (1999). Role of accurate mass measure-
ment (+/− 10 ppm) in protein identification strategies employing MS or 
MS/MS and database searching. Anal Chem 71, 2871–2882.
Cornea-Hebert V, Watkins KC, Roth BL, Kroeze WK, Gaudreau P, Leclerc N, 
Descarries L (2002). Similar ultrastructural distribution of the 5-HT(2A) 
serotonin receptor and microtubule-associated protein MAP1A in 
cortical dendrites of adult rat. Neuroscience 113, 23–35.
Doyon C, Moraru A, Richard D (2004). The corticotropin-releasing factor 
system as a potential target for antiobesity drugs. Drug News Perspect 
17, 505–517.
Gao F, Harikumar KG, Dong M, Lam PC, Sexton PM, Christopoulos A, Bord-
ner A, Abagyan R, Miller LJ (2009). Functional importance of a structur-
ally distinct homodimeric complex of the family B G protein-coupled 
secretin receptor. Mol Pharmacol 76, 264–274.
Gao MH, Giamouridis D, Lai NC, Walenta E, Paschoal VA, Kim YC, Miyano-
hara A, Guo T, Liao M, Liu L, et al. (2016). One-time injection of AAV8 
encoding urocortin 2 provides long-term resolution of insulin resistance. 
JCI Insight 1, e88322.
Gingras AC, Aebersold R, Raught B (2005). Advances in protein complex 
analysis using mass spectrometry. J Physiol 563, 11–21.
Gottlieb TA, Ivanov IE, Adesnik M, Sabatini DD (1993). Actin microfilaments 
play a critical role in endocytosis at the apical but not the basolateral 
surface of polarized epithelial cells. J Cell Biol 120, 695–710.
Grammatopoulos DK (2012). Insights into mechanisms of corticotropin-
releasing hormone receptor signal transduction. Br J Pharmacol 166, 
85–97.
Grammatopoulos DK, Randeva HS, Levine MA, Katsanou ES, Hillhouse EW 
(2000). Urocortin, but not corticotropin-releasing hormone (CRH), acti-
vates the mitogen-activated protein kinase signal transduction pathway 
in human pregnant myometrium: an effect mediated via R1alpha and 
R2beta CRH receptor subtypes and stimulation of Gq-proteins. Mol 
Endocrinol 14, 2076–2091.
Guan S, Price JC, Prusiner SB, Ghaemmaghami S, Burlingame AL (2011). 
A data processing pipeline for mammalian proteome dynamics stud-
ies using stable isotope metabolic labeling. Mol Cell Proteomics 10, 
M111 010728.
Harikumar KG, Morfis MM, Lisenbee CS, Sexton PM, Miller LJ (2006). 
Constitutive formation of oligomeric complexes between family 
B G protein-coupled vasoactive intestinal polypeptide and secretin 
receptors. Mol Pharmacol 69, 363–373.
Hasdemir B, Bunnett NW, Cottrell GS (2007). Hepatocyte growth factor-
regulated tyrosine kinase substrate (HRS) mediates post-endocytic 
trafficking of protease-activated receptor 2 and calcitonin receptor-like 
receptor. J Biol Chem 282, 29646–29657.
Hasdemir B, Mahajan S, Bunnett NW, Liao M, Bhargava A (2012). Endothe-
lin-converting enzyme-1 actions determine differential trafficking and 
signaling of corticotropin-releasing factor receptor 1 at high agonist 
concentrations. Mol Endocrinol 26, 681–695.
Henckens MJ, Deussing JM, Chen A (2016). Region-specific roles of 
the corticotropin-releasing factor-urocortin system in stress. Nat Rev 
Neurosci 17, 636–651.
Hotta M, Shibasaki T, Arai K, Demura H (1999). Corticotropin-releasing 
factor receptor type 1 mediates emotional stress-induced inhibition of 
food intake and behavioral changes in rats. Brain Res 823, 221–225.
Kalwat MA, Thurmond DC (2013). Signaling mechanisms of glucose-
induced F-actin remodeling in pancreatic islet beta cells. Exp Mol Med 
45, e37.
Kim OJ, Ariano MA, Lazzarini RA, Levine MS, Sibley DR (2002). Neurofila-
ment-M interacts with the D1 dopamine receptor to regulate cell surface 
expression and desensitization. J Neuroscience 22, 5920–5930.
Lai NC, Gao MH, Giamouridis D, Suarez J, Miyanohara A, Parikh J, High-
tower S, Guo T, Dillmann W, Kim YC, et al. (2015). Intravenous AAV8 
encoding urocortin-2 increases function of the failing heart in mice. 
Hum Gene Ther 26, 347–356.
Lamaze C, Fujimoto LM, Yin HL, Schmid SL (1997). The actin cytoskeleton is 
required for receptor-mediated endocytosis in mammalian cells. J Biol 
Chem 272, 20332–20335.
Levoye A, Dam J, Ayoub MA, Guillaume JL, Jockers R (2006). Do orphan 
G-protein-coupled receptors have ligand-independent functions? New 
insights from receptor heterodimers. EMBO Rep 7, 1094–1098.
REFERENCES
Alken M, Rutz C, Kochl R, Donalies U, Oueslati M, Furkert J, Wietfeld D, 
Hermosilla R, Scholz A, Beyermann M, et al. (2005). The signal peptide 
of the rat corticotropin-releasing factor receptor 1 promotes receptor 
expression but is not essential for establishing a functional receptor. 
Biochem J 390, 455–464.
Bhargava A (2011). CRF and urocortins: a challenging interaction between 
family members. Gastroenterology 140, 1391–1394.
Binda AV, Kabbani N, Lin R, Levenson R (2002). D2 and D3 dopamine 
receptor cell surface localization mediated by interaction with protein 
4.1N. Mol Pharmacol 62, 507–513.
Bockaert J, Fagni L, Dumuis A, Marin P (2004). GPCR interacting proteins 
(GIP). Pharmacol Ther 103, 203–221.
Boulant S, Kural C, Zeeh JC, Ubelmann F, Kirchhausen T (2011). Actin 
dynamics counteract membrane tension during clathrin-mediated 
endocytosis. Nat Cell Biol 13, 1124–1131.
Volume 28 September 1, 2017 CRF receptor heteromers | 2399 
Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogen-
esch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE (2001). Urocortin 
II: a member of the corticotropin-releasing factor (CRF) neuropeptide 
family that is selectively bound by type 2 CRF receptors. Proc Natl Acad 
Sci USA 98, 2843–2848.
Rodbell M (1995). Nobel Lecture. Signal transduction: evolution of an idea. 
Biosci Rep 15, 117–133.
Rosenfeld J, Capdevielle J, Guillemot JC, Ferrara P (1992). In-gel digestion 
of proteins for internal sequence analysis after one- or two-dimensional 
gel electrophoresis. Anal Biochem 203, 173–179.
Rutz C, Renner A, Alken M, Schulz K, Beyermann M, Wiesner B, Rosenthal 
W, Schulein R (2006). The corticotropin-releasing factor receptor type 
2a contains an N-terminal pseudo signal peptide. J Biol Chem 281, 
24910–24921.
Schulz K, Rutz C, Westendorf C, Ridelis I, Vogelbein S, Furkert J, Schmidt 
A, Wiesner B, Schulein R (2010). The pseudo signal peptide of the 
corticotropin-releasing factor receptor type 2a decreases receptor ex-
pression and prevents Gi-mediated inhibition of adenylyl cyclase activity. 
J Biol Chem 285, 32878–32887.
Sexton PM, Morfis M, Tilakaratne N, Hay DL, Udawela M, Christopoulos G, 
Christopoulos A (2006). Complexing receptor pharmacology: modula-
tion of family B G protein-coupled receptor function by RAMPs. Ann NY 
Acad Sci 1070, 90–104.
Singh VP, Saluja AK, Bhagat L, Hietaranta AJ, Song A, Mykoniatis A, Van 
Acker GJ, Steer ML (2001). Serine protease inhibitor causes F-actin 
redistribution and inhibition of calcium-mediated secretion in pancreatic 
acini. Gastroenterology 120, 1818–1827.
Springael JY, Urizar E, Costagliola S, Vassart G, Parmentier M (2007). Al-
losteric properties of G protein-coupled receptor oligomers. Pharmacol 
Ther 115, 410–418.
Teichmann A, Gibert A, Lampe A, Grzesik P, Rutz C, Furkert J, Schmoran-
zer J, Krause G, Wiesner B, Schulein R (2014). The specific monomer/
dimer equilibrium of the corticotropin-releasing factor receptor type 1 is 
established in the endoplasmic reticulum. J Biol Chem 289, 24250–
24262.
Teichmann A, Rutz C, Kreuchwig A, Krause G, Wiesner B, Schulein R 
(2012). The pseudo signal peptide of the corticotropin-releasing factor 
receptor type 2A prevents receptor oligomerization. J Biol Chem 287, 
27265–27274.
Trester-Zedlitz M, Burlingame A, Kobilka B, von Zastrow M (2005). Mass 
spectrometric analysis of agonist effects on posttranslational modifica-
tions of the beta-2 adrenoceptor in mammalian cells. Biochemistry 44, 
6133–6143.
Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan 
R, Turnbull AV, Lovejoy D, Rivier C, et al. (1995). Urocortin, a mammalian 
neuropeptide related to fish urotensin I and to corticotropin-releasing 
factor. Nature 378, 287–292.
Vischer HF, Castro M, Pin JP (2015). G protein-coupled receptor multimers: 
a question still open despite the use of novel approaches. Mol Pharma-
col 88, 561–571.
Vischer HF, Watts AO, Nijmeijer S, Leurs R (2011). G protein-coupled recep-
tors: walking hand-in-hand, talking hand-in-hand. Br J Pharmacol 163, 
246–260.
Zhao GQ, Zhang Y, Hoon MA, Chandrashekar J, Erlenbach I, Ryba NJ, 
Zuker CS (2003). The receptors for mammalian sweet and umami taste. 
Cell 115, 255–266.
Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, 
Reyes TM, Gulyas J, Fischer W, et al. (2001). Identification of urocortin 
III, an additional member of the corticotropin-releasing factor (CRF) 
family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 
98, 7570–7575.
Magalhaes AC, Holmes KD, Dale LB, Comps-Agrar L, Lee D, Yadav PN, 
Drysdale L, Poulter MO, Roth BL, Pin JP, et al. (2010). CRF receptor 1 
regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. 
Nat Neurosci 13, 622–629.
Mahajan S, Liao M, Barkan P, Takahashi K, Bhargava A (2014). Urocor-
tin 3 expression at baseline and during inflammation in the colon: 
corticotropin releasing factor receptors cross-talk. Peptides 54, 58–66.
Margeta-Mitrovic M, Jan YN, Jan LY (2000). A trafficking checkpoint controls 
GABA(B) receptor heterodimerization. Neuron 27, 97–106.
Markovic D, Lehnert H, Levine MA, Grammatopoulos DK (2008). Structural 
determinants critical for localization and signaling within the seventh 
transmembrane domain of the type 1 corticotropin releasing hormone 
receptor: lessons from the receptor variant R1d. Mol Endocrinol 22, 
2505–2519.
Markovic D, Vatish M, Gu M, Slater D, Newton R, Lehnert H, Grammatopou-
los DK (2007). The onset of labor alters corticotropin-releasing hormone 
type 1 receptor variant expression in human myometrium: putative role 
of interleukin-1beta. Endocrinology 148, 3205–3213.
Milligan G (2009). G protein-coupled receptor hetero-dimerization: contri-
bution to pharmacology and function. Br J Pharmacol 158, 5–14.
Muglia L, Jacobson L, Dikkes P, Majzoub JA (1995). Corticotropin-releasing 
hormone deficiency reveals major fetal but not adult glucocorticoid 
need. Nature 373, 427–432.
Murat B, Devost D, Andres M, Mion J, Boulay V, Corbani M, Zingg HH, 
Guillon G (2012). V1b and CRHR1 receptor heterodimerization mediates 
synergistic biological actions of vasopressin and CRH. Mol Endocrinol 
26, 502–520.
Neufeld-Cohen A, Tsoory MM, Evans AK, Getselter D, Gil S, Lowry CA, Vale 
WW, Chen A (2010). A triple urocortin knockout mouse model reveals 
an essential role for urocortins in stress recovery. Proc Natl Acad Sci USA 
107, 19020–19025.
O’Callaghan DW, Hasdemir B, Leighton M, Burgoyne RD (2003). Residues 
within the myristoylation motif determine intracellular targeting of the 
neuronal Ca2+ sensor protein KChIP1 to post-ER transport vesicles and 
traffic of Kv4 K+ channels. J Cell Sci 116, 4833–4845.
Pal K, Swaminathan K, Xu HE, Pioszak AA (2010). Structural basis for hor-
mone recognition by the Human CRFR2α G protein-coupled receptor. J 
Biol Chem 285, 40351–40361.
Paul NR, Allen JL, Chapman A, Morlan-Mairal M, Zindy E, Jacquemet G, 
Fernandez Del Ama L, Ferizovic N, Green DM, Howe JD, et al. (2015). 
α5β1 integrin recycling promotes Arp2/3-independent cancer cell inva-
sion via the formin FHOD3. J Cell Biol 210, 1013–1031.
Perrin MH, DiGruccio MR, Koerber SC, Rivier JE, Kunitake KS, Bain DL, 
Fischer WH, Vale WW (2003). A soluble form of the first extracellular 
domain of mouse type 2β corticotropin-releasing factor receptor reveals 
differential ligand specificity. J Biol Chem 278, 15595–15600.
Reisine T, Rougon G, Barbet J, Affolter HU (1985). Corticotropin-releasing 
factor-induced adrenocorticotropin hormone release and synthesis is 
blocked by incorporation of the inhibitor of cyclic AMP-dependent 
protein kinase into anterior pituitary tumor cells by liposomes. Proc Natl 
Acad Sci USA 82, 8261–8265.
